Abstract
The dynamics of zoonotic infectious diseases with silent circulation may be imperfectly understood and monitored using passive (or reactive) epidemiological surveillance data only, highlighting the interest of quantitative methods like modelling. West Nile virus (WNV) is a widespread mosquito-borne virus transmitted from birds to “dead-end” hosts including humans and horses, in whom it can be fatal. It was first detected in Guadeloupe archipelago, Caribbean, in 2002, although no WNV clinical case in humans nor horses had been reported before 2024. Undetected infections represent a risk as WNV can be transmitted via blood and organ donations. In Guadeloupe, epidemiological surveillance started in 2002 in sentinel chickens and horses and in 2015 in mosquitoes, to detect WNV and to improve knowledge on its epidemiology and dynamics. In order to reconstruct the WNV force of infection (FOI), we built a model assessing different hypotheses regarding its dynamics using serological results in respectively 1,022 and 3,649 blood samples collected from 256 horses and 317 chickens between 2002 and 2018. We fitted the model to the serological data using Markov Chains Monte Carlo. We found that WNV FOI in Guadeloupe Island presented both within-year (seasonal) and between-years fluctuations. We identified three main episodes of WNV circulation on the island between 2002 and 2017. During years with circulation, the FOI was predicted to be highest around the months of October-November, although transmission could occur all year long. We estimated a very low weekly seroreversion rate, which is consistent with a lifelong persistence of WNV IgG antibodies in many infected individuals. To conclude, combining longitudinal serological data to a mathematical model allowed reconstructing the recurrent and silent circulation of WNV in this Caribbean island, which could improve surveillance design for better virus detection.
Competing Interest Statement
The authors have declared no competing interest.
Funding Statement
This work was supported by the BCOMING project (Horizon Europe project 101059483) funded by the European Union, by a DIM1Health postdoctoral fellowship awarded by the Conseil Regional d'Ile-de-France and by the EU project MALIN and the Guadeloupe Regional Council under the European Research and Development Funds (ERDF) 2014-2020 program (Grant 2018-FED-1084). Surveillance data collection was funded by local veterinary services (DAAF971).
Author Declarations
I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.
Yes
I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.
Yes
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Yes
I have followed all appropriate research reporting guidelines, such as any relevant EQUATOR Network research reporting checklist(s) and other pertinent material, if applicable.
Yes
Data availability statement
Data is presented within the paper and its supplementary material. Code reproducing the article is available from the following link: https://github.com/JonathanBas/West_Nile_model_Guadeloupe.
